The Current Ratio as of November 2024 (TTM) for Frequency Therapeutics, Inc. (FREQ) is 4.42

According to Frequency Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.42. This represents a change of 0.85% compared to the average of 4.38 of the last 4 quarters.

Frequency Therapeutics, Inc. (FREQ) Historical Current Ratio (quarterly & annually)

How has FREQ Current Ratio performed in the past?

The mean historical Current Ratio of Frequency Therapeutics, Inc. over the last ten years is 6.86. The current 4.42 Current Ratio has changed 6.34% with respect to the historical average. Over the past ten years (40 quarters), FREQ's Current Ratio was at its highest in in the June 2021 quarter at 19.09. The Current Ratio was at its lowest in in the September 2018 quarter at 0.

Frequency Therapeutics, Inc. (FREQ) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Frequency Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Frequency Therapeutics, Inc. (FREQ) Average Current Ratio

How has FREQ Current Ratio performed in the past?

The current Current Ratio of Frequency Therapeutics, Inc. (FREQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Frequency Therapeutics, Inc. (FREQ) Current Ratio vs. Peers

How is FREQ’s Current Ratio compared to its peers?

Frequency Therapeutics, Inc.’s Current Ratio is greater than Lineage Cell Therapeutics, Inc. (2.48), greater than MAIA Biotechnology, Inc. (2.56), greater than Armata Pharmaceuticals, Inc. (0.19), greater than Portage Biotech Inc. (1.73), less than PMV Pharmaceuticals, Inc. (13.98), less than Olema Pharmaceuticals, Inc. (7.10), greater than Enochian Biosciences, Inc. (0.08), greater than Scholar Rock Holding Corporation (3.88), less than Passage Bio, Inc. (5.15), less than Shattuck Labs, Inc. (7.96), less than C4 Therapeutics, Inc. (6.31), less than Eliem Therapeutics, Inc. (60.41), less than Prelude Therapeutics Incorporated (7.04), less than Monte Rosa Therapeutics, Inc. (6.03), less than Absci Corporation (0), less than Adverum Biotechnologies, Inc. (5.63), less than Kezar Life Sciences, Inc. (5.82), less than Oncternal Therapeutics, Inc. (7.65), greater than null (2.39),

Build a custom stock screener for Frequency Therapeutics, Inc. (FREQ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Frequency Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Frequency Therapeutics, Inc. (FREQ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Frequency Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.